Copyright © Inderes 2011 - present. All rights reserved.
Logga in för att få aviseringar
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet
Regulatoriskt pressmeddelande

Change in Modulight Corporation’s holding of treasury shares and annulment of option rights

2024-12-30 15:00
Modulight

Modulight Corporation | Company Release | December 30, 2024 at 16:00:00 EET

Modulight Corporation issued 815,859 new shares and 852,758 option rights to its employees in a personnel share issue in September 2021. The issuance of shares was carried out in deviation from shareholders’ pre-emptive right (directed issue) in order to engage and retain employees.
 
Modulight Corporation has today acquired a total of 79,816 shares subscribed in the personnel share issue from an employees whose employment with Modulight Corporation has ended, in accordance with the terms and conditions of the directed share issue. The purchase price is EUR 0.32 per share, which is the original subscription price. In addition, Modulight Corporation annuls 79,989 option rights which have been returned to the possession of Modulight Corporation due to an ended employment.
 
The shares were acquired on 30th of December 2024. After the acquisition, Modulight Corporation holds a total of 79,816 new treasury shares. After the annulment of the option rights, Modulight Corporation does not hold any option rights.

For further information, please contact:


CEO Seppo Orsila, m. +358 40 830 4671

IR Ulla Haapanen, m. +358 40 830 4676
Email: ir@modulight.com

Certified adviser: Sisu Partners Oy, m. +358 40 555 4727
 
modulight.com
@modulight

Modulight in brief


Modulight Corporation is a biomedical laser company that designs and manufactures products for oncology, ophthalmology and genetics. The company also provides solutions for selected high value-add applications including quantum computing and digital press. The company’s products include medical devices, subsystems, software, cloud services and specialized semiconductors. Modulight’s products are used worldwide by many Fortune 500 companies, pharmaceutical companies, and well-known cancer centers and universities. Modulight was founded in 2000 and is headquartered in Tampere, Finland.

Follow Modulight: modulight.com | X | LinkedIn | Facebook | YouTube | Instagram | #killcancer #laserfamily

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.